A lactulose hydrogen breath test was performed on 10
Introduction
Abnormal breath hydrogen concentrations after ingestion of glucose in patients with bacterial colonisation of the small intestine was first described by Bond and Levitt.' This finding was confirmed by Metz et al2 and more recently by Rhodes et al, who used lactulose instead of glucose.3 Measurement of breath hydrogen concentrations after ingestion of lactulose may also be used to estimate small-intestinal transit time. 4 The test is based on the fact that lactulose is not absorbed in the small intestine in man. On reaching the colon it is fermented by bacteria and hydrogen is released, which is then absorbed and exhaled. The rate of production of hydrogen in the colon is accurately reflected by breath hydrogen concentrations,6 hydrogen appearing in the breath within about five minutes of lactulose coming into contact with bacteria in the gut. 4 We performed the hydrogen breath test in patients with cystic fibrosis to detect possible bacterial colonisation of the small intestine. This may occur in cystic fibrosis because infected sputum is continually produced and swallowed. If present this may contribute to the persistent steatorrhoea noted in patients with. cystic fibrosis despite treatment with pancreatic enzymes and cimetidine.7
Subjects and methods
We studied 10 patients with cystic fibrosis (seven men, three women, aged [17] [18] [19] [20] [21] [22] [23] [24] Small-bowel transit time has not been studied previously in patients with cystic fibrosis, although Weber et all'6 studied mouth to anus transit time in 24 children (aged 2 months to 9 years) with the disease and found it to be rapid (untreated children 13-2±5-4 hours; normal 25-4±7-6 hours). Many other workers have suggested a possible disorder of intestinal motility in cystic fibrosis.7 I1 Our results support this hypothesis. Delayed small-intestinal transit in cystic fibrosis might be related to viscid intestinal mucus slowing propulsion of food along the intestine. An intrinsic defect in contraction of intestinal smooth muscle or altered gastrointestinal hormone concentrations in the disease may also effect motility.18 Finally, apparent delay in small-bowel transit time might be due to delayed gastric emptying, but this has not been studied in adults with cystic fibrosis.
Prolonged small-intestinal transit time in cystic fibrosis could have clinical implications. It might be relevant to the 10% incidence of small-intestinal obstruction (meconium ileus equivalent).'9 Moreover, intestinal motility is one of the important factors in controlling bacterial colonisation in the intestine,20 21 and therefore delayed small-bowel transit time in cystic fibrosis may encourage bacterial overgrowth of the small bowel (as seen in one of our patients), which in turn might increase malabsorption and further contribute to malnutrition. Oral iron and the bioavailability of zinc N J MEADOWS, S L GRAINGER, WARWICK RUSE, P W N KEELING, R P H THOMPSON Abstract The oral bioavailability of zinc was studied in nonpregnant adults before and 24 hours after two weeks of oral supplementation with iron and folic acid. Bioavailability was greatly reduced, and the shape of the plasma curves suggested that this was due to impairment of the intestinal absorption of zinc.
The findings suggest that the reduced bioavailability of zinc occurs because of interelement competition in the bowel wall. This might induce zinc depletion.
Introduction
We have reported that depletion of zinc in maternal tissues is strongly associated with depletion of zinc in fetal tissues and with idiopathic retardation of intrauterine growth.' The mechanisms responsible for maternal depletion are unknown, but in our local population a major cause is probably poor dietary intake, particularly as available zinc is present chiefly in expensive, high protein foods. In addition, dietary metals compete for intestinal absorption,' and therefore routine iron supple- ments during pregnancy may decrease the absorption of zinc from the gut. Indeed, Solomons and Jacob3 reported that oral iron given concurrently with zinc to non-pregnant adults results in impaired oral bioavailability (or area under the plasma concentration time curve) of zinc. More prolonged effect of iron, however, has not been assessed.
We have studied the oral bioavailability of zinc given before and after oral supplementation with iron and folic acid.
Patients and methods
After a 12 hour fast 10 subjects (five men) were given 50 mg elemental zinc (220 mg zinc sulphate capsules) by mouth. Two baseline 5 ml venous blood samples were taken through a heparinised butterfly cannula before dosing, and then at 30 minute intervals for six hours. The blood was transferred into plastic heparinised tubes, the plasma separated at 400 g for 20 minutes at 20°C, and two 1 ml aliquots of plasma-each diluted with 9 ml 1 OM HCl-assayed for zinc concentration by atomic absorption spectrophotometry (model IL 257, Instrumentation Laboratories).
Each subject was then given oral iron and folic acid supplements as one Pregaday tablet (ferrous fumarate (100 mg iron) and folic acid 350 ,ug) daily for 14 days and zinc bioavailability reassessed 24 hours after the last dose.
In two healthy adults the reproducibility of the areas under the plasma concentration time curves in response to the oral administration of zinc sulphate (220 mg) was studied five times at two week intervals.
The elimination rate constant was calculated by least squares regression analysis of the log plasma zinc concentrations from 30 minutes after the peak until return to the baseline. The time to peak, peak plasma concentration, area under the curve, and elimination rate constant were compared before and after supplementation by two tailed Student's t test.
All patients gave written, informed consent and the study was approved by the hospital's ethical committee.
